Myriad Genetics, Inc. Settlement
(NASDAQ: MYGN)
Settlement

Claim Deadline: January 16, 2024

Settlement Fund: $77,500,000

Settlement Class

All persons who purchased or acquired Myriad common stock from August 9, 2017 until February 6, 2020, inclusive.

Important Documents

Settlement Status

Final Approval Granted

Class Period

August 09, 2017 - February 06, 2020

Settlement Hearing Date

December 08, 2023

Opt-Out Deadline

November 17, 2023

Claims Admin

A.B. Data, Ltd.
Myriad Genetics Securities Litigation
c/o A.B. Data, Ltd.
P.O. Box 170500
Milwaukee,  WI 53217

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.